Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors
Related Posts
Donovan FM, Thompson GR 3rd, Blair JE, Johnson RH, Malo J, Albasha W, Worrell SG, Beamer SE, Yaddanapudi K, Galgiani JN, Ampel NM. How I[...]
Shieh A, Karlamangla AS, Gossiel F, Eastell R, Burnett-Bowie SA, Greendale GA. Estimating net bone formation relative to resorption using reference bone turnover markers. J[...]
Helminski D, Sussman JB, Pfeiffer PN, Kokaly AN, Ranusch A, Renji AD, Damschroder LJ, Landis-Lewis Z, Kurlander JE. Development, Implementation, and Evaluation Methods for Dashboards[...]